Christopher W.G. Redman

ORCID: 0000-0001-9738-5290
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Reproductive System and Pregnancy
  • Pregnancy and Medication Impact
  • Neonatal and fetal brain pathology
  • Maternal and fetal healthcare
  • Neonatal Respiratory Health Research
  • Gestational Diabetes Research and Management
  • Prenatal Screening and Diagnostics
  • Extracellular vesicles in disease
  • Cardiovascular Issues in Pregnancy
  • Blood Coagulation and Thrombosis Mechanisms
  • Preterm Birth and Chorioamnionitis
  • Phonocardiography and Auscultation Techniques
  • Maternal and Perinatal Health Interventions
  • MicroRNA in disease regulation
  • Selenium in Biological Systems
  • COVID-19 Impact on Reproduction
  • Non-Invasive Vital Sign Monitoring
  • Cell Adhesion Molecules Research
  • Parvovirus B19 Infection Studies
  • Assisted Reproductive Technology and Twin Pregnancy
  • Global Maternal and Child Health
  • IL-33, ST2, and ILC Pathways
  • Infant Nutrition and Health

John Radcliffe Hospital
2013-2024

University of Oxford
2015-2024

Cincinnati Children's Hospital Medical Center
2018

Nuffield Orthopaedic Centre
1983-2018

Brunel University of London
2017

University of Reading
2017

Karolinska University Hospital
2017

Karolinska Institutet
2017

University of Tampa
2017

Sahlgrenska University Hospital
2017

Cellular microvesicles and nanovesicles (exosomes) are involved in many disease processes have major potential as biomarkers. However, developments this area constrained by limitations the technology available for their measurement. Here we report on use of fluorescence nanoparticle tracking analysis (NTA) to rapidly size phenotype cellular vesicles. In system vesicles visualized light scattering using a microscope. A video is taken, NTA software tracks brownian motion individual calculates...

10.1016/j.nano.2011.04.003 article EN cc-by Nanomedicine Nanotechnology Biology and Medicine 2011-05-07

Preeclampsia is a serious complication of pregnancy in which the fetus receives an inadequate supply blood due to failure trophoblast invasion. There evidence that condition has immunological basis. The only known polymorphic histocompatibility antigens on fetal are HLA-C molecules. We tested idea recognition these molecules by killer immunoglobulin receptors (KIRs) maternal decidual NK cells key factor development preeclampsia. Striking differences were observed when ligand: receptor pairs...

10.1084/jem.20041214 article EN The Journal of Experimental Medicine 2004-10-11

To measure the incidence of eclampsia, establish how often it is preceded by signs pre-eclampsia, document morbidity associated with and determine maternal case fatality rates.A prospective, descriptive study every eclampsia in United Kingdom 1992. Information was collected from reviews hospital notes questionnaires to general practitioners.All 279 hospitals a consultant obstetric unit.Obstetricians midwives notified 582 possible cases, 383 were confirmed as eclampsia. The national...

10.1136/bmj.309.6966.1395 article EN BMJ 1994-11-26

The ability to determine fetal RhD status noninvasively is useful in the treatment of RhD-sensitized pregnant women whose partners are heterozygous for gene. recent demonstration DNA maternal plasma raises possibility that genotyping may be possible with use plasma.

10.1056/nejm199812103392402 article EN New England Journal of Medicine 1998-12-10

Nanoparticle tracking analysis (NTA) is a light-scattering technique that useful for the rapid sizing and enumeration of extracellular vesicles (EVs). As relatively new method, NTA has been criticised lack standardisation. We propose use silica microspheres calibration measurements describe in detail protocol EVs by which should minimise many sources variability imprecision associated with this technique.

10.3402/jev.v2i0.19671 article EN cc-by-nc Journal of Extracellular Vesicles 2013-01-01

Abstract Background: There is much recent interest in the biologic and diagnostic implication of cell-free non-host DNA plasma serum human subjects. To determine if quantitative abnormalities circulating may be associated with certain pathologic processes, we used fetal preeclampsia as a model system. Methods: We studied 20 preeclamptic women control subjects comparable gestational age (means, 32 33 weeks, respectively). Male maternal was measured using real-time PCR for SRY gene on Y...

10.1093/clinchem/45.2.184 article EN Clinical Chemistry 1999-02-01

Background— Hypertensive disorders of pregnancy are a major contributor to death and disability for pregnant women their infants. The diagnosis preeclampsia by using blood pressure proteinuria is limited use because they tertiary, downstream features the disease. Placental growth factor (PlGF) an angiogenic factor, secondary marker associated placental dysfunction in preeclampsia, with known low plasma concentrations Methods Results— In prospective multicenter study, we studied diagnostic...

10.1161/circulationaha.113.003215 article EN Circulation 2013-11-04

Abstract Systemic inflammatory responsiveness was studied in normal human pregnancy and its specific disorder, pre-eclampsia. Compared with nonpregnancy, monocytes were primed to produce more TNF-α throughout pregnancy, IL-12p70 the first second trimesters, IL-18 trimester only. Intracellular cytokine measurements (TNF-α IL12p70) showed little change by comparison. IFN-γ production suppressed all three trimesters. In pre-eclampsia, secretion increased. Secreted but not intracellular measures...

10.4049/jimmunol.178.9.5949 article EN The Journal of Immunology 2007-05-01

Generalised maternal endothelial cell dysfunction appears to be an underlying problem in pre-eclampsia presumed caused, directly or indirectly, by one more circulating factors derived from the placenta. Recently it has been suggested that tumour necrosis factor (TNF) may play important role and contribute activation. This study was designed investigate this proposal.Plasma TNF-alpha, IL-6 both forms of soluble TNF receptors (p55 p75 TNF-R) have measured ELISA 31 pre-eclamptic patients...

10.1111/j.1471-0528.1995.tb09020.x article EN BJOG An International Journal of Obstetrics & Gynaecology 1995-01-01
Coming Soon ...